ESG

Alabama is launching a statewide traffic overhaul, using smart tech to analyze 1,149 signals, promising smoother commutes and safer roads for all.

A new partnership signals a major shift in the aesthetics market, blending private equity scale with a new focus on university-backed provider education.

The 'Beauty in Black' star, whose character has prostate cancer, is now a Global Ambassador for ZERO, tackling the disease's deadly toll on Black men.

Red Light Holland is deploying advanced AI from Kala Bio to accelerate its botanical psilocybin program, signaling a new high-tech era for mental health.

A new 720 kW rooftop solar project at a Mercedes-Benz facility in California highlights a strategic shift for businesses seeking cost control and resilience.

The company launches new research assays for pTau217, entering a competitive field aimed at replacing invasive tests with a simple blood draw.

In a bid to bolster US energy security, Eagle Nuclear hires SLR to navigate permitting for its Aurora project, aiming for FAST-41 status.

As AI pushes grids to the brink, Exowatt opens a new Texas facility to deploy its modular, clean power solutions, aiming to reshape energy infrastructure.

The rapidly growing clean wine brand Avaline is placing new sales leaders in key cities, signaling an aggressive push for national market dominance.

With new execs from Grail and Eli Lilly, ClearNote Health signals a major push to get its AI-powered cancer detection tests through trials and into the market.

Cingulate Inc. faces a critical FDA decision for its novel ADHD drug, but manufacturing queries and a tight cash runway create a high-stakes countdown.

Swiss firm H55's flight-proven batteries are fast-tracking a new hybrid-electric regional aircraft demonstrator, promising a 30% leap in fuel efficiency.

A new book by a neurologist, attorney, and MBA argues that five powerful systems are contributing to a crisis in children's neurodevelopment.

With a massive $68.7M seed round and novel T-cell engager tech, Shanghai's Excalipoint is pioneering a new model for rapid drug development.

As transit goes electric, moviTHERM and Troman Industries unite to offer a platform for detecting battery fire risks before they ignite, aiming for safer fleets.

A new AI-powered blood test for early liver cancer detection is now accessible nationwide through Quest Diagnostics, aiming to improve dismal screening rates.

InflaRx announces a late-breaking presentation on its Phase 3 trial for vilobelimab, offering potential new hope for pyoderma gangrenosum patients.

A new partnership between US-based InCharge Energy and Canada's RocketEV promises to solve the biggest headache for electric fleets: charger reliability.

A new partnership in Western Canada will use German tech to convert wood waste into high-quality biochar, generating carbon credits and clean energy.

Denver-based Xcimer Energy completes key experiments, advancing its methodical plan to turn the promise of laser fusion into a commercial reality.